Abstract
Background & Aim: This meta-analysis was performed to quantify the effects of probiotics on renal and glycemic biomarkers among patients with Diabetic Nephropathy (DN).
Methods: Electronic databases were searched on May 10, 2020. All trials that investigated the effect of probiotics on serum glycemic markers (Fasting Plasma Glucose [FPG], Hemoglobin A1C, Insulin, Homeostatic Model Assessment-Insulin Resistance [HOMA-IR], and Quantitative Insulin Sensitivity Check Index [QUICKI]), and renal status markers (Creatinine [Cr], Blood Urea Nitrogen [BUN], and Glomerular Filtration Rate [GFR]) were included.
Results: Seven trials that included 340 patients were identified for analysis. The results indicated that probiotics significantly reduced FPG (WMD= -19.08 mg/dl; 95% CI= -32.16, -5.99; P=0.004), HOMA-IR (WMD= -1.88; 95% CI= -3.63, -0.12; P=0.036), and Cr (WMD= -0.18 mg/dl; 95% CI= -0.26, -0.09; P<0.001) levels in DN patients; however, there was no statistically significant change in Hemoglobin A1C, Insulin, QUICKI, BUN, and GFR.
Conclusion: This meta-analysis supports the potential use of probiotics in the improvement of some glycemic and renal biomarkers in patients with DN.
Keywords: Probiotics, clinical laboratory techniques, diabetic nephropathies, meta-analysis, systematic review, clinical trials.
[http://dx.doi.org/10.1007/978-3-319-93521-8_7]
[http://dx.doi.org/10.1007/978-1-4939-9841-8_1]
[http://dx.doi.org/10.1111/j.1523-1755.2005.00265.x] [PMID: 15840014]
[http://dx.doi.org/10.1159/000431333] [PMID: 26067713]
[http://dx.doi.org/10.1016/j.phrs.2018.01.013] [PMID: 29378252]
[http://dx.doi.org/10.1016/j.coph.2019.03.011] [PMID: 31015106]
[http://dx.doi.org/10.7150/thno.40571] [PMID: 32194836]
[http://dx.doi.org/10.1093/ndt/gfy413] [PMID: 30698804]
[http://dx.doi.org/10.1016/j.nutres.2015.03.002] [PMID: 25818484]
[http://dx.doi.org/10.1007/s11154-014-9288-6] [PMID: 24789701]
[http://dx.doi.org/10.1038/nrgastro.2017.75] [PMID: 28611480]
[http://dx.doi.org/10.1016/j.cofs.2020.01.003]
[http://dx.doi.org/10.1089/bfm.2019.0301] [PMID: 32311272]
[http://dx.doi.org/10.12659/AJCR.912023] [PMID: 31000688]
[http://dx.doi.org/10.3892/ijmm.2020.4495] [PMID: 32124946]
[http://dx.doi.org/10.1007/s11033-020-05254-4] [PMID: 31919753]
[http://dx.doi.org/10.1016/j.jff.2017.09.033]
[http://dx.doi.org/10.1016/j.jbiosc.2010.07.006] [PMID: 20691633]
[http://dx.doi.org/10.1007/s12602-018-9468-x] [PMID: 30218286]
[http://dx.doi.org/10.1080/10408398.2020.1740645] [PMID: 32329633]
[http://dx.doi.org/10.1053/j.jrn.2018.08.008] [PMID: 30366767]
[http://dx.doi.org/10.1159/000494677] [PMID: 30380555]
[http://dx.doi.org/10.2174/1574884715666200303112753] [PMID: 32124701]
[http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00136] [PMID: 19622512]
[http://dx.doi.org/10.1186/1471-2288-5-13] [PMID: 15840177]
[PMID: 28174351]
[http://dx.doi.org/10.1039/C8FO00888D] [PMID: 30113051]
[http://dx.doi.org/10.1016/j.kint.2016.09.040] [PMID: 27927601]
[http://dx.doi.org/10.1053/j.jrn.2017.04.004] [PMID: 28579313]
[http://dx.doi.org/10.1007/s12602-017-9325-3] [PMID: 28884306]
[http://dx.doi.org/10.15171/jnp.2018.25]
[http://dx.doi.org/10.1111/nep.13549] [PMID: 30561114]
[http://dx.doi.org/10.1016/j.nut.2018.01.007] [PMID: 29626749]
[http://dx.doi.org/10.1016/j.medici.2015.11.008] [PMID: 26987497]
[http://dx.doi.org/10.12659/MSM.902600] [PMID: 28638006]
[http://dx.doi.org/10.1007/s40199-019-00302-2] [PMID: 31691101]
[http://dx.doi.org/10.1016/j.diabres.2016.06.014] [PMID: 27388674]
[http://dx.doi.org/10.1016/j.jff.2019.103614]
[http://dx.doi.org/10.1016/j.metabol.2019.154013] [PMID: 31734275]
[http://dx.doi.org/10.1016/j.biopha.2017.08.117] [PMID: 28946394]
[http://dx.doi.org/10.1016/j.chom.2012.10.012] [PMID: 23159051]
[http://dx.doi.org/10.1002/14651858.CD005573.pub3]